Steven’s Story
My name is Steven Hadfield. I am 70 years old, a long-time North Carolinian, a husband, a grandfather of three, and a football fanatic. I’m also a rare cancer and type 2 diabetes patient.
The current drug pricing system isn’t working for patients like me.
My name is Emily. I’m a 26-year-old from Washington, D.C., and I live with psoriatic arthritis.
PRESS CONFERENCE: P4AD’s David Mitchell Says House Oversight Committee Report Drives Home Need For Swift Senate Passage Of BBB To Reform Broken Drug Pricing System
The Build Back Better Act “Will Make Our System Work Better For Those It Is Intended To Serve: Patients And All Americans”
ICYMI: New Video Tells The Truth About COVID-19 Vaccines
Government And Taxpayers Saved The Day; Drug Corporations Did Their Job, Then Cashed In
The time for change is now
If Medicare were able to negotiate drug prices, then all seniors would be given the relief they deserve. The time for change is now.
RELEASE: Setting The Record Straight — New Fact Check Exposes Big Pharma’s Lies About Medicare Negotiation
Patients For Affordable Drugs Responds To The Industry’s $18 Million Attack Ads Aimed At Thwarting Reforms To Lower Drug Prices
STATEMENT: P4AD Applauds FDA’s Approval Of First Interchangeable Biosimilar Insulin, Calls For Affordable Insulin For All
The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an important step forward on the road to real competition.
NEW ANALYSIS: Drug Companies Continue To Hike Prices At Will; Congress Must Act
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
